DAFNA Capital Management as of March 31, 2026
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 83 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Revolution Medicines (RVMD) | 12.8 | $57M | 581k | 97.25 | |
| Spdr S&p Biotech Etf Etf (XBI) | 9.3 | $41M | 319k | 127.73 | |
| Stereotaxis Com New (STXS) | 5.7 | $25M | 14M | 1.84 | |
| Day One Biopharmaceuticals I (DAWN) | 4.8 | $21M | 979k | 21.44 | |
| AtriCure (ATRC) | 3.9 | $17M | 597k | 28.53 | |
| Ideaya Biosciences (IDYA) | 3.6 | $16M | 477k | 33.32 | |
| Xenon Pharmaceuticals (XENE) | 3.3 | $15M | 251k | 58.15 | |
| Cytokinetics Com New (CYTK) | 3.3 | $14M | 218k | 65.91 | |
| Compass Pathways Sponsored Ads (CMPS) | 3.0 | $13M | 2.4M | 5.53 | |
| Nektar Therapeutics Com New (NKTR) | 2.7 | $12M | 165k | 71.95 | |
| Ishares Nasdaq Biotech Indx Etf (IBB) | 2.4 | $11M | 62k | 168.85 | |
| Arcus Biosciences Incorporated (RCUS) | 2.2 | $9.6M | 444k | 21.60 | |
| Neurocrine Biosciences (NBIX) | 2.1 | $9.3M | 71k | 131.74 | |
| Larimar Therapeutics (LRMR) | 2.1 | $9.1M | 2.0M | 4.50 | |
| Bicara Therapeutics (BCAX) | 1.9 | $8.4M | 422k | 19.89 | |
| Axogen (AXGN) | 1.9 | $8.3M | 250k | 33.13 | |
| Biohaven (BHVN) | 1.6 | $7.2M | 846k | 8.46 | |
| Tandem Diabetes Care Com New (TNDM) | 1.5 | $6.8M | 355k | 19.17 | |
| Denali Therapeutics (DNLI) | 1.4 | $6.1M | 319k | 19.20 | |
| Ascendis Pharma A/s Note 2.250% 4/0 (Principal) | 1.3 | $5.9M | 4.0M | 1.48 | |
| Century Therapeutics (IPSC) | 1.3 | $5.5M | 2.4M | 2.26 | |
| Dex (DXCM) | 1.2 | $5.4M | 86k | 62.80 | |
| Kalvista Pharmaceuticals (KALV) | 1.2 | $5.4M | 267k | 20.13 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 1.2 | $5.3M | 23k | 228.73 | |
| Mbx Biosciences (MBX) | 1.2 | $5.2M | 176k | 29.85 | |
| Inogen (INGN) | 1.2 | $5.2M | 845k | 6.18 | |
| Syndax Pharmaceuticals (SNDX) | 1.2 | $5.1M | 217k | 23.36 | |
| Alkermes SHS (ALKS) | 1.1 | $4.9M | 140k | 35.36 | |
| Stoke Therapeutics (STOK) | 1.0 | $4.3M | 131k | 32.56 | |
| BioCryst Pharmaceuticals (BCRX) | 0.9 | $4.1M | 430k | 9.52 | |
| Galapagos Nv Spon Adr (GLPG) | 0.9 | $3.9M | 130k | 30.00 | |
| Immunovant (IMVT) | 0.9 | $3.7M | 151k | 24.84 | |
| Edgewise Therapeutics (EWTX) | 0.8 | $3.5M | 112k | 31.50 | |
| Maplight Therapeutics (MPLT) | 0.8 | $3.5M | 171k | 20.33 | |
| Allogene Therapeutics (ALLO) | 0.8 | $3.3M | 1.4M | 2.44 | |
| Procept Biorobotics Corp (PRCT) | 0.7 | $3.0M | 120k | 25.01 | |
| Align Technology (ALGN) | 0.6 | $2.6M | 15k | 171.43 | |
| Proqr Therapeutics N V Shs Euro (PRQR) | 0.6 | $2.5M | 1.6M | 1.62 | |
| Cybin Com New (HELP) | 0.5 | $2.4M | 498k | 4.80 | |
| Rapport Therapeutics (RAPP) | 0.5 | $2.3M | 75k | 31.29 | |
| Insulet Corporation (PODD) | 0.5 | $2.3M | 11k | 209.84 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.5 | $2.2M | 47k | 48.20 | |
| Immatics Nv SHS (IMTX) | 0.5 | $2.2M | 226k | 9.84 | |
| Celldex Therapeutics Com New (CLDX) | 0.5 | $2.2M | 69k | 31.72 | |
| Lexeo Therapeutics (LXEO) | 0.5 | $2.2M | 377k | 5.74 | |
| Alector (ALEC) | 0.4 | $2.0M | 908k | 2.15 | |
| Viking Therapeutics (VKTX) | 0.4 | $1.9M | 60k | 32.54 | |
| Kura Oncology (KURA) | 0.4 | $1.9M | 236k | 8.13 | |
| Profound Medical Corp Com New (PROF) | 0.4 | $1.7M | 263k | 6.48 | |
| Fulcrum Therapeutics (FULC) | 0.4 | $1.6M | 205k | 7.67 | |
| Aquestive Therapeutics (AQST) | 0.3 | $1.5M | 368k | 4.15 | |
| Mediwound Shs New (MDWD) | 0.3 | $1.5M | 94k | 16.11 | |
| Orthopediatrics Corp. (KIDS) | 0.3 | $1.5M | 96k | 15.87 | |
| Ultragenyx Pharmaceutical (RARE) | 0.3 | $1.3M | 61k | 20.95 | |
| Engene Holdings (ENGN) | 0.3 | $1.3M | 187k | 6.81 | |
| Neurogene (NGNE) | 0.3 | $1.1M | 57k | 20.16 | |
| Silverback Therapeutics (SPRY) | 0.3 | $1.1M | 139k | 8.03 | |
| Cytomx Therapeutics (CTMX) | 0.2 | $1.1M | 230k | 4.70 | |
| Maze Therapeatics (MAZE) | 0.2 | $1.0M | 35k | 29.85 | |
| Mineralys Therapeutics (MLYS) | 0.2 | $1.0M | 39k | 27.09 | |
| Scynexis Com New (SCYX) | 0.2 | $997k | 1.1M | 0.92 | |
| Oric Pharmaceuticals (ORIC) | 0.2 | $946k | 99k | 9.58 | |
| Inspire Med Sys (INSP) | 0.2 | $939k | 18k | 51.58 | |
| Polypid (PYPD) | 0.2 | $911k | 208k | 4.38 | |
| Tela Bio (TELA) | 0.2 | $893k | 1.4M | 0.62 | |
| Zenas Biopharma (ZBIO) | 0.2 | $831k | 43k | 19.55 | |
| Verrica Pharmaceuticals Com Shs (VRCA) | 0.2 | $813k | 154k | 5.29 | |
| Fate Therapeutics (FATE) | 0.2 | $660k | 550k | 1.20 | |
| Annexon (ANNX) | 0.1 | $653k | 118k | 5.54 | |
| Accuray Incorporated (ARAY) | 0.1 | $652k | 1.7M | 0.39 | |
| Newamsterdam Pharma Ordinary Shares (NAMS) | 0.1 | $640k | 20k | 32.01 | |
| Adicet Bio Com New (ACET) | 0.1 | $639k | 94k | 6.81 | |
| Biontech Se Sponsored Ads (BNTX) | 0.1 | $622k | 7.0k | 88.88 | |
| Pliant Therapeutics (PLRX) | 0.1 | $614k | 487k | 1.26 | |
| Compugen Ord (CGEN) | 0.1 | $549k | 258k | 2.13 | |
| Health Sciences Acq Corp 2 (OBIO) | 0.1 | $539k | 127k | 4.25 | |
| Foghorn Therapeutics (FHTX) | 0.1 | $535k | 112k | 4.78 | |
| Ibio Com New (IBIO) | 0.1 | $368k | 194k | 1.90 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.1 | $299k | 65k | 4.64 | |
| Adc Therapeutics Sa SHS (ADCT) | 0.1 | $270k | 72k | 3.75 | |
| Karyopharm Therapeutics Com New (KPTI) | 0.1 | $255k | 46k | 5.57 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $248k | 179k | 1.38 | |
| Neumora Therapeutics (NMRA) | 0.0 | $137k | 70k | 1.95 |
